Your Customer Isn’t a Physician Anymore: Selling to IDNs, GPOs, and Organized Buyers

The traditional pharmaceutical sales model was built on a simple premise: convince physicians to prescribe your product. Representatives called on doctors, delivered clinical messages, and success was measured in prescription volume. That model isn’t dead, but it’s no longer sufficient.

Today, getting a physician to write a prescription is just one hurdle in a series of obstacles between your product and the patient. The payer has to cover it. The health system has to include it on their formulary. The practice’s prescribing protocols have to allow it. Each of these decision points involves different stakeholders with different priorities, and increasingly, these organized customers hold more influence over prescribing decisions than individual physicians do.

Understanding this shift, and adapting commercial capabilities accordingly, has become essential for pharmaceutical companies competing in the current environment.

The Rise of Organized Customers

The healthcare landscape has consolidated dramatically. Integrated Delivery Networks (IDNs) now control significant portions of patient care in most metropolitan areas. Group Purchasing Organizations (GPOs) aggregate buying power across thousands of facilities. Large medical groups, some with hundreds of physicians, establish their own formularies and treatment protocols.

These organized customers make decisions differently than individual physicians. Where a physician might be persuaded by clinical data in a one-on-one conversation, an IDN’s Pharmacy & Therapeutics Committee evaluates products against system-wide priorities: total cost of care, quality metrics, operational fit, and alignment with value-based contracts.

The math has changed as well. When physician practices operated independently, pharmaceutical companies could build market share one prescription at a time. Now, a single formulary decision by a major health system can determine access for thousands of patients. The stakes of each organized customer interaction have increased significantly.

What Organized Customers Want

Engaging organized customers effectively requires understanding what drives their decisions. While clinical efficacy and safety remain foundational, these stakeholders evaluate products through a broader lens.

• Clinical value still matters, but it is evaluated in context. How does this product fit into existing treatment protocols? Does it address gaps in current care pathways?
• Economic value has become central to the conversation. Beyond acquisition cost, organized customers want to understand total cost of care implications.
• Operational fit affects adoption. Products that integrate smoothly into existing workflows face lower barriers than those requiring significant operational changes.
• Quality and outcomes alignment connects product value to the metrics that matter to these customers. Health systems are increasingly measured and reimbursed based on quality scores and population health outcomes.

The Capability Gap

Most pharmaceutical sales organizations were not built for this environment. Traditional representatives were trained in product knowledge and clinical selling. They called on physicians, delivered approved messages, and tracked call activity. The skills required to engage organized customers are fundamentally different.

Account management in this context requires understanding how different healthcare entities make decisions, who influences those decisions, and what information they need. It requires navigating complex stakeholder maps and building relationships at multiple levels of an organization.

This isn’t about replacing clinical knowledge with business acumen. It’s about adding business acumen to clinical knowledge.

The Role Evolution

As organized customers have grown in importance, new roles have emerged and existing roles have evolved.

Strategic Account Managers (SAMs) or Key Account Managers (KAMs) focus on the most important organized customers. They develop deep understanding of their accounts, coordinate cross-functional engagement, and build senior-level relationships. These roles require different competencies than traditional sales positions.

Field sales representatives increasingly need “mini account manager” skills. Even when calling on individual physicians, they need to understand what’s driving those physicians’ behaviors—which often traces back to health system priorities, quality metrics, and reimbursement pressures.

Field leadership roles have evolved as well. Managers now need to coach on account management skills, not just call execution.

The Deployment Question

One size doesn’t fit all markets. The degree of healthcare consolidation varies significantly by geography. In some markets, a handful of health systems dominate. In others, independent practices remain common. The optimal deployment model depends on the local landscape.

Organizations that deploy the same selling model everywhere miss this nuance. Understanding the healthcare ecosystem in each geography should inform deployment decisions—and this requires ongoing analysis as markets continue to consolidate.

Building the Capabilities That Matter

The shift to organized customers isn’t coming—it’s here. Organizations that continue operating as if the physician is still the only customer that matters will find themselves increasingly locked out of decisions that determine market access.

Building account management capabilities across field roles requires more than a single training event. It requires sustained investment in how customer-facing teams understand the marketplace, engage stakeholders, and create value for organized customers.

The customer has changed. The capabilities required to serve them must change as well.

WLH Consulting has helped pharmaceutical commercial organizations build account management capabilities for over two decades. To discuss how your team can adapt to the organized customer landscape, contact us at wendy@wlhconsulting.com

References

1. Physicians Advocacy Institute (2024). Updated Physician Practice Acquisition Study.

2. Portch, M. (2024). Interview on pharmaceutical market access evolution. WLH Consulting, Inc.

3. WLH Consulting, Inc. (2024). Account Management Academy Program.

4. WLH Consulting, Inc. (2024). Pharma Sales Force Transformation Capabilities.